QUOTE AND NEWS
StreetInsider.com  May 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Columbia+Laboratories%2C+Inc.+%28CBRX%29+Misses+Q1+EPS+by+2c/8320360.html for the full story.
Benzinga  Apr 9  Comment 
Columbia Laboratories (NASDAQ: CBRX) has amended its license and supply agreement with Merck Serono, a division of Merck KGaA (MRK.DE), Darmstadt, Germany, for CRINONE® (progesterone gel) through May 2020, representing an extension of five years...
StreetInsider.com  Mar 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Columbia+Laboratories%2C+Inc.+%28CBRX%29+Tops+Q4+EPS+Views+by+50%25/8183989.html for the full story.
Benzinga  Mar 6  Comment 
Columbia Laboratories (NSDAQ: CBRX) today announced that its Board of Directors on March 1, 2013 adopted an amendment to its Stockholder Rights Plan (the "Rights Plan"), originally adopted on March 12, 2002, to extend the...
StreetInsider.com  Nov 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Columbia+Laboratories%2C+Inc.+%28CBRX%29+Misses+Q3+EPS+by+1c/7855866.html for the full story.
StreetInsider.com  Oct 26  Comment 
Columbia Laboratories Inc. (Nasdaq: CBRX) 41.8% LOWER; confirmed that the U.S. Food and Drug Administration (FDA) has denied Watson Pharmaceuticals’ (NYSE: WPI) Formal Dispute Resolution Request (FDRR) related to its New Drug Application (NDA...
Benzinga  Oct 26  Comment 
Columbia Laboratories Inc. (Nasdaq: CBRX) today confirmed that the U.S. Food and Drug Administration (FDA) has denied Watson Pharmaceuticals' (NYSE: WPI) Formal Dispute Resolution Request (FDRR) related to its New Drug Application (NDA 22-139) for...
Benzinga  Oct 25  Comment 
Columbia Laboratories (NASDAQ: CBRX) received a letter on October 24, 2012, from the Nasdaq Stock Market indicating that the Company no longer meets the minimum bid price requirement for continued listing on the Nasdaq Global...
StreetInsider.com  Sep 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Columbia+Laboratories+%28CBRX%29+Regains+NASDAQ+Compliance/7709182.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki